Home › Funds › MOODY LYNN LIEBERSON & WALKER, LLC › GILD

MOODY LYNN LIEBERSON & WALKER, LLC position in GILD

GILEAD SCIENCES INC · Health Care

MOODY LYNN LIEBERSON & WALKER, LLC reported holding 123,572 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$18.4M, representing 0.96% of its reported portfolio and ranking #30 among its reported holdings. MOODY LYNN LIEBERSON & WALKER, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)123.57K sh
Reported value held$18.42M
Portfolio Weight0.96%
First reportedQ3 2023
Last changeAdd
Updated2026-10-14

Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR

How MOODY LYNN LIEBERSON & WALKER, LLC's GILD position evolved

MOODY LYNN LIEBERSON & WALKER, LLC first disclosed a stake in GILD in Q3 2023 at 5,056 shares (US$379K). The position peaked in Q3 2026 at 123,572 shares, worth US$18.4M. Across 13 filings, MOODY LYNN LIEBERSON & WALKER, LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 123,572 shares valued at US$18.4M — an increase of 18,038 shares quarter over quarter.. Notable position changes include a 334% increase in Q4 2024 (shares rose 21% over the following quarter), a 216% increase in Q1 2025 (shares were roughly flat over the following quarter), a 46% increase in Q4 2025 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.06K $378.90K New
Q4 2023 5.06K $409.59K Hold
Q1 2024 4.88K $357.68K Reduce
Q2 2024 4.88K $335.02K Hold
Q3 2024 4.91K $411.65K Add
Q4 2024 21.31K $1.97M Add
Q1 2025 67.41K $7.55M Add
Q2 2025 65.95K $7.31M Reduce
Q3 2025 66.55K $7.39M Add
Q4 2025 97.30K $11.94M Add
Q1 2026 119.26K $16.62M Add
Q2 2026 105.53K $13.33M Reduce
Q3 2026 123.57K $18.42M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has MOODY LYNN LIEBERSON & WALKER, LLC held GILD?

MOODY LYNN LIEBERSON & WALKER, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MOODY LYNN LIEBERSON & WALKER, LLC's current position in GILD?

As of Q3 2026, MOODY LYNN LIEBERSON & WALKER, LLC holds 123.57K shares of GILD (GILEAD SCIENCES INC), valued at $18.42M, representing 0.96% of its reported portfolio and ranking #30.

Has MOODY LYNN LIEBERSON & WALKER, LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), MOODY LYNN LIEBERSON & WALKER, LLC increased its position in GILD. The position peaked in Q3 2026 at 123.57K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.